Bridging the Gap Between CKD Management Paradigms in Transplant and Nontransplant Settings: Published Evidence,...

Area of Science:

• Nephrology
• Transplantation Immunology
• Clinical Medicine

Background:

• Kidney transplantation (KT) is the optimal treatment for end-stage renal disease, improving survival and quality of life over dialysis.
• Post-KT patients often experience reduced estimated glomerular filtration rate (eGFR), leading to prevalent chronic kidney disease (CKD) complications.
• The mechanisms and management of CKD complications in KT recipients differ from non-transplant CKD populations, with limited evidence-based guidelines.

Purpose of the Study:

• To review the challenges in managing reduced eGFR in kidney transplant recipients.
• To synthesize current evidence on managing CKD complications in the post-KT setting.
• To identify critical knowledge gaps regarding the application of novel CKD therapies in KT patients.

Main Methods:

• Literature review of studies on kidney transplantation and chronic kidney disease management.
• Analysis of evidence concerning the prevalence and mechanisms of CKD complications after KT.
• Evaluation of emerging therapies for CKD and their potential impact on KT outcomes.

Main Results:

• Reduced eGFR is a frequent complication after KT, contributing to significant morbidity.
• CKD complications in KT patients have unique pathophysiological aspects compared to non-transplant CKD.
• Evidence for using new CKD therapies in the post-KT population is largely lacking.

Conclusions:

• Managing reduced eGFR and associated CKD complications in KT recipients presents unique challenges.
• Further research is crucial to investigate the efficacy and safety of novel CKD therapies in the post-KT setting.
• Addressing knowledge gaps will optimize long-term outcomes for kidney transplant patients.